Escitalopram Oxalate
CAS No. 219861-08-2
Escitalopram Oxalate( Escitalopram Oxalate | Cipralex | Lexapro )
Catalog No. M18247 CAS No. 219861-08-2
Escitalopram Oxalate is a selective serotonin (5-HT) reuptake inhibitor (SSRI) with Ki of 0.89 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 45 | Get Quote |
|
| 50MG | 55 | Get Quote |
|
| 100MG | 75 | Get Quote |
|
| 200MG | 114 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEscitalopram Oxalate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEscitalopram Oxalate is a selective serotonin (5-HT) reuptake inhibitor (SSRI) with Ki of 0.89 nM.
-
DescriptionEscitalopram Oxalate is a furancarbonitrile that is one of the selective serotonin uptake inhibitors used as an antidepressant. As a selective serotonin reuptake inhibitor (SSRI), escitalopram blocks the reuptake of serotonin by neurons in the central nervous system (CNS), thereby potentiating CNS serotonergic activity. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition.
-
In Vitro——
-
In VivoAnimal Model:Male Sprague-Dawley ratsDosage:10 mg/kg Administration:I.p.; daily for 28 days Result:Could selectively decrease phosphorylated tau accumulation in the hippocampus of stressed rats and could distinctly alleviate the hyperactivity of the HPA axis in both depressive and resistant rats.Animal Model:APP-PS1 hemizygous female mice (4 months of age)Dosage:2.5-5 mg/kg Administration:Daily; drinking water for a total of 4 months Result:At both doses significantly reduced plaque burden within the brains of these mice compared to littermate controls that drank only water. Hippocampal plaque load was significantly reduced by 28.7% and 34.4 % for ESC 2.5 mg/day and 5 mg/day, respectively.
-
SynonymsEscitalopram Oxalate | Cipralex | Lexapro
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorSSRI
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number219861-08-2
-
Formula Weight414.43
-
Molecular FormulaC22H23FN2O5
-
Purity>98% (HPLC)
-
SolubilityH2O : ≥ 14.29 mg/mL; 34.48 mM
-
SMILESCN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O
-
Chemical Name(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;oxalic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mnie-Filali O, et al. Encephale, 2007, 33(6), 965-972.
molnova catalog
related products
-
JWG-071
JWG-071, the first reported chemical probe for ERK5 kinase selectivity, is a BET-selective inhibitor with a 1 μM BRD4 IC that enhances both ERK5 activity and BRD4 selectivity.
-
DW71177
DW71177 is a bd1-selective and potent BET inhibitor with potent anti-leukemic activity for the study of leukemia.
-
OXF BD 02
OXF BD 02 is a potent and selective BRD4(1) inhibitor (IC50: 382 nM) with anticancer and anti-inflammatory activity.
Cart
sales@molnova.com